Retention Time Repeatability in Peptide Mapping under Shallow Gradient Conditions Using Nexera X4

Importance of the topic

Peptide mapping is a cornerstone analytical method for verifying primary structure, sequence integrity and post‑translational modifications of therapeutic proteins. Reliable separation of hundreds of enzymatic digestion products often requires long runs with very shallow reversed‑phase gradients. Under these conditions, tiny variations in mobile phase composition or detector baseline stability translate into retention time drift and reduced confidence in peak identification. Achieving highly reproducible retention times is therefore essential for robust identity, comparability and stability testing in biopharmaceutical workflows.

Objectives and overview of the study

This technical evaluation aimed to assess retention time repeatability for peptide mapping under shallow gradient conditions using the Shimadzu Nexera X4 UHPLC platform. The study used tryptic digests of myoglobin as a complex peptide mixture, compared Nexera X4 performance with a typical UHPLC system, and quantified retention time variability across non‑retained, isocratic and shallow gradient segments.

Methodology

Sample preparation and experimental design:

• Sample: Myoglobin (horse) digested with trypsin; digestion performed at 37 °C for 20 hours and quenched with formic acid.
• Sample dilution: digestion products diluted with mobile phase A prior to injection.
• Evaluation: 17 representative peptide peaks selected; retention times measured in replicate injections (n = 6) to calculate %RSD as the metric of repeatability.

Chromatographic conditions (key parameters summarized):

• Column: Shim‑pack Scepter C18, 100 mm × 2.1 mm i.d., 1.9 µm.
• Column temperature: 65 °C; flow rate: 0.2 mL/min (MR‑20 mixer).
• Mobile phases: A = 0.1% trifluoroacetic acid (TFA) in water; B = 0.1% TFA in acetonitrile.
• Gradient program: initial B 1% (0–3 min), shallow ramp to 50% B by 88 min, steep to 90% B at 90–100 min, re‑equilibration to 1% B by 102–130 min.
• Injection volume: 10 µL; detection at 214 nm for peptide absorbance.

Used Instrumentation

The study highlights specific hardware and design elements of the Nexera X4 responsible for improved repeatability:

• Nexera X4 UHPLC system platform.
• LC‑40B X4 binary gradient pump with four independently actuated plungers and a pressure feedback mechanism to optimize suction/discharge timing and minimize pump‑origin pulsation.
• SPD‑M40 X4 photodiode array detector featuring a redesigned capillary flow cell and optics to reduce refractive index effects during gradient elution, improving baseline stability at short wavelengths.
• Shim‑pack Scepter C18 analytical column (100 × 2.1 mm, 1.9 µm).
• Ancillary components: MR‑20 mixer, sample loop 15 µL.

Main results and discussion

Chromatographic separation and retention stability:

• The shallow gradient separated a large number of peptide fragments from the tryptic myoglobin digest, producing dense but well‑resolved chromatograms.
• Overlay of repeated injections showed consistent peak patterns, indicating stable retention behavior across runs.

Retention time repeatability performance:

• The Nexera X4 delivered markedly improved retention time repeatability (%RSD) compared with a representative typical UHPLC system across three regimes: non‑retained front (t0), isocratic segments, and the shallow gradient region.
• Improvements are attributed to reduced pump pulsation (due to independent plunger control and pressure feedback) and reduced refractive index–induced baseline fluctuation by the SPD‑M40 X4 detector, which together stabilize peak detection at low wavelengths used for peptides.

Practical implications of results:

• Lower retention variability reduces false peak identity assignments and supports tighter acceptance criteria in quality control and comparability assays.
• Improved baseline stability enhances detection of low‑concentration peptides, especially important when working near 214 nm.

Benefits and practical applications

The demonstrated improvements support several routine and advanced applications in analytical and regulatory environments:

• More reliable peptide mapping for identity, batch release and stability studies in biopharmaceutical QC laboratories.
• Reduction in method development time and re‑analysis due to improved run‑to‑run stability under long, shallow gradients.
• Enhanced sensitivity and quantitation for low abundance peptides owing to reduced baseline noise and refractive index artifacts.
• Applicability to other complex proteomic separations requiring extended shallow gradients and high retention reproducibility.

Future trends and applications

Anticipated directions building on these findings include:

• Integration with high‑resolution mass spectrometry for peptide identification workflows requiring both chromatographic reproducibility and MS sensitivity.
• Further pump and detector refinements to support even flatter gradients, higher pressures and smaller particle chemistries.
• Adoption of automated sample preparation and on‑line digestion to pair stable separations with high throughput workflows.
• Use of machine learning models for retention time prediction and automated peak alignment that benefit from reduced instrumental variability.
• Wider acceptance of such hardware advances in regulatory method validation and transfer for biotherapeutic products.

Conclusion

The Nexera X4 system, driven by the LC‑40B X4 pump and SPD‑M40 X4 detector, provides demonstrably superior retention time repeatability and baseline stability for peptide mapping under demanding shallow gradient conditions. These improvements increase confidence in peptide identification and quantitation in biopharmaceutical analyses and reduce analytical risk in long‑run separations typical of complex peptide mixtures.

References

Technical Report: Nakajima K., Kuriki T., Matsumoto K. Retention Time Repeatability in Peptide Mapping under Shallow Gradient Conditions Using Nexera X4. Shimadzu Corporation; First Edition March 2026; Report C190‑E343.